The additional evaluation of IDH1 expression in non-small-cell lung cancer (NSCLC) through the screening of a large population identified IDH1 as a diagnostic biomarker, owing to its favourable sensitivity and specificity [4,5]. This evidence concerns the gene IDH1 and non-small cell lung carcinoma.